Sensitivity analysis indicated that no individual study significantly influenced the difference on RBP4 levels between patients with NAFLD and healthy controls (Additional file 3: Figure S1). The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.